Q4 2025 Holdings
Filed 2026-02-17 | 77 holdings | $430.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $48.1M | 604,514 | 11.2% |
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $41.0M | 336,505 | 9.5% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $31.5M | 13,680,554 | 7.3% |
| Atricure Inc(ATRC) | COM | 04963C209 | $23.6M | 597,431 | 5.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $23.6M | 370,997 | 5.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $17.5M | 506,740 | 4.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $15.6M | 476,826 | 3.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.9M | 287,939 | 3.0% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $11.5M | 68,095 | 2.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $10.8M | 955,235 | 2.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $10.3M | 431,329 | 2.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $10.0M | 70,615 | 2.3% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.3M | 999,163 | 2.2% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $7.8M | 355,208 | 1.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.0M | 28,177 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.9M | 88,279 | 1.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.8M | 277,855 | 1.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.8M | 356,802 | 1.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.6M | 811,046 | 1.3% |
| Inogen Inc(INGN) | COM | 45780L104 | $5.6M | 827,071 | 1.3% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $5.5M | $4,000,000 | 1.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $5.3M | 318,500 | 1.2% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $5.2M | 165,265 | 1.2% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $4.4M | 261,583 | 1.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.3M | 130,175 | 1.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.0M | 304,775 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.0M | 159,736 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.8M | 150,524 | 0.9% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $3.8M | 120,000 | 0.9% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $3.7M | 455,018 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.6M | 130,248 | 0.8% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.6M | 939,164 | 0.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.5M | 108,875 | 0.8% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $3.4M | 340,859 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.3M | 418,255 | 0.8% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $3.2M | 74,998 | 0.7% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $3.2M | 1,567,561 | 0.7% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.8M | 2,793,586 | 0.6% |
| Immatics NV(IMTX) | SHS | N44445109 | $2.7M | 261,138 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.6M | 37,000 | 0.6% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $2.5M | 143,764 | 0.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $2.5M | 16,000 | 0.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.5M | 235,868 | 0.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.4M | 375,915 | 0.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $2.3M | 75,000 | 0.5% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $2.2M | 285,710 | 0.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $2.2M | 190,065 | 0.5% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.1M | 113,612 | 0.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.1M | 59,516 | 0.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.0M | 6,870 | 0.5% |